We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,585
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$536M |
| 2 |
Procter & Gamble
PG
|
+$358M |
| 3 |
CSX Corp
CSX
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$186M |
| 5 |
Eli Lilly
LLY
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$370M |
| 2 |
American Electric Power
AEP
|
+$338M |
| 3 |
Alibaba
BABA
|
+$322M |
| 4 |
Prologis
PLD
|
+$307M |
| 5 |
HEICO Corp
HEI
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Financials | 13.75% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Corcept Therapeutics
CORT
$12B
| $528K | ﹤0.01% |
7,212
-12,735
| -64% | -$923K |
|
1277
British American Tobacco
BTI
$128B
| $525K | ﹤0.01% |
11,100
| – | – |
|
1278
BioMarin Pharmaceuticals
BMRN
$11.6B
| $524K | ﹤0.01% |
9,542
+3,298
| +53% | +$194K |
|
1279
EverCommerce
EVCM
$2.1B
| $523K | ﹤0.01% |
49,859
+49,041
| +5,995% | +$495K |
|
1280
Sumitomo Mitsui Financial
SMFG
$161B
| $521K | ﹤0.01% |
34,528
+454
| +1% | +$6.53K |
|
1281
Highwoods Properties
HIW
$3.58B
| $520K | ﹤0.01% |
16,764
+120
| +0.7% | +$3.53K |
|
1282
Universal Logistics Holdings
ULH
$485M
| $520K | ﹤0.01% |
20,569
+1,361
| +7% | +$33.7K |
|
1283
Tyson Foods
TSN
$20.5B
| $516K | ﹤0.01% |
9,247
+960
| +12% | +$55.2K |
|
1284
E.W. Scripps
SSP
$263M
| $515K | ﹤0.01% |
175,192
-165,440
| -49% | -$400K |
|
1285
Group 1 Automotive
GPI
$3.31B
| $514K | ﹤0.01% |
1,177
+534
| +83% | +$224K |
|
1286
Orion
OEC
$370M
| $514K | ﹤0.01% |
49,022
+464
| +1% | +$5.25K |
|
1287
Peapack-Gladstone Financial
PGC
$822M
| $506K | ﹤0.01% |
17,940
+1,442
| +9% | +$39.6K |
|
1288
Okta
OKTA
$25.6B
| $504K | ﹤0.01% |
5,043
-12,968
| -72% | -$1.38M |
|
1289
SITE Centers
SITC
$172M
| $504K | ﹤0.01% |
44,587
+10,013
| +29% | +$120K |
|
|
CRWV
1290
CoreWeave
CRWV
$49B
| $503K | ﹤0.01% |
+3,090
| New | +$285K |
|
|
LTM
1291
LATAM Airlines Group S.A.
LTM
$16.6B
| $500K | ﹤0.01% |
+12,327
| New | +$427K |
|
|
TEAD
1292
Teads Holding Co
TEAD
$80.2M
| $496K | ﹤0.01% |
200,112
+148,790
| +290% | +$450K |
|
1293
Bilibili
BILI
$7.78B
| $495K | ﹤0.01% |
23,115
-101,921
| -82% | -$1.88M |
|
1294
Bioventus
BVS
$1.03B
| $495K | ﹤0.01% |
74,919
+65,410
| +688% | +$464K |
|
1295
Trinity Industries
TRN
$2.59B
| $492K | ﹤0.01% |
18,226
-4,339
| -19% | -$112K |
|
1296
Twilio
TWLO
$29.3B
| $492K | ﹤0.01% |
3,958
+3,914
| +8,895% | +$416K |
|
1297
Consolidated Edison
ED
$40B
| $491K | ﹤0.01% |
4,900
-689
| -12% | -$72.9K |
|
1298
Boot Barn
BOOT
$4.88B
| $486K | ﹤0.01% |
3,212
-212
| -6% | -$28.1K |
|
1299
Murphy Oil
MUR
$5.17B
| $482K | ﹤0.01% |
21,472
+1,259
| +6% | +$28.1K |
|
1300
Xometry
XMTR
$5.29B
| $482K | ﹤0.01% |
14,282
+8,831
| +162% | +$259K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lazard Asset Management held 2,585 positions worth $72.7B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.34B in Q2 2025, closing 298 positions and reducing 728 holdings. Its most notable exit was Eastman Chemical, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Arcos Dorados Holdings worth $117M.
- Lazard Asset Management's largest Q2 2025 buy was Arcos Dorados Holdings: 14,873,278 shares worth $117M.
- Lazard Asset Management added most to Crown Castle in Q2 2025, an estimated $536M increase.
- Lazard Asset Management's biggest Q2 2025 reduction was NetEase, cutting an estimated $370M.
- Lazard Asset Management fully exited Eastman Chemical in Q2 2025, selling an estimated $13.1M.
- Lazard Asset Management's ten largest holdings make up 24% of its $72.7B portfolio in Q2 2025.
- Lazard Asset Management opened 253 new positions and closed 298 in Q2 2025.
- Lazard Asset Management's portfolio value rose 12% quarter-over-quarter to $72.7B.
Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.